Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01984619 · ClinicalTrials.gov registry record

Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles

A clinical trial of Wrinkles, sponsored by Pacira Pharmaceuticals.

Completed
Registry status
47
Enrollment target
1
Study location

NCT01984619: Completed study of Wrinkles, sponsored by Pacira Pharmaceuticals.

NCT01984619 is a study of Wrinkles that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 47 participants, roughly in line with the 50-participant average among 7 other Wrinkles trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01984619, a study of Wrinkles, has completed, sponsored by Pacira Pharmaceuticals.

COMPLETED
Registry status
47 participants
Enrollment target
1
Study location

Study Summary

To evaluate the safety and effectiveness of the iovera° device with the blunt tip cannula for the treatment of forehead wrinkles.

Conditions Studied

Interventions

  • DEVICE Cryotherapy for the utilization of wrinkle reduction (iovera)

Study Locations (1)

California

  • The Aesthetics Research Center - Redwood City

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2013-09
Est. Completion 2014-09
Pacira Pharmaceuticals

88 total trials

What the finished NCT01984619 record still lists

NCT01984619 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target, roughly in line with the 50-participant average among 7 other Wrinkles trials with a reported enrollment target.

The record links to 1 condition, with Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Cryotherapy for the utilization of wrinkle reduction (iovera) is the first listed.

NCT01984619 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01984619 about?

NCT01984619 is a clinical study titled "Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles". To evaluate the safety and effectiveness of the iovera° device with the blunt tip cannula for the treatment of forehead wrinkles.

What is the current status of trial NCT01984619?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2013-09. Estimated completion is 2014-09.

What conditions does trial NCT01984619 study?

This clinical trial studies the following conditions: Wrinkles.

What interventions are being tested in trial NCT01984619?

The interventions under investigation include: Cryotherapy for the utilization of wrinkle reduction (iovera) (DEVICE).

Who is sponsoring clinical trial NCT01984619?

This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01984619 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkles

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01984619, the US trial registry maintained by the National Library of Medicine. NCT01984619 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.